P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY

• Pankaj Malhotra,
• Sharat Damodar,
• Sunil Bhat,
• Raja Thirumalairaj,
• Revathy Raj,
• Akshatha Nayak,
• Pooja Mallya,
• Ravi Joshi,
• Deepak Mb,
• Sudarshan Chougule,
• Sudeshna Dhar,
• Arun Kumar Mg,
• Pallavi Arasu,
• Sri Ramulu Elluru,
• Mohammed Manzoor Akheel,
• Anil Kamat

Affiliations

Pankaj Malhotra

1 Postgraduate Institute of Medical Education and Research, Chandigarh, India

Sharat Damodar

2 Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India

Sunil Bhat

2 Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India

Raja Thirumalairaj

3 Apollo Speciality Hospital, Chennai, India

Revathy Raj

3 Apollo Speciality Hospital, Chennai, India

Akshatha Nayak

2 Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India

Pooja Mallya

2 Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India

Ravi Joshi

2 Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India

Deepak Mb

2 Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India

Sudarshan Chougule

2 Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India

Sudeshna Dhar

4 Immuneel Therapeutics Private Limited, Bengaluru, India

Arun Kumar Mg

4 Immuneel Therapeutics Private Limited, Bengaluru, India

Pallavi Arasu

4 Immuneel Therapeutics Private Limited, Bengaluru, India

Sri Ramulu Elluru

4 Immuneel Therapeutics Private Limited, Bengaluru, India

Mohammed Manzoor Akheel

4 Immuneel Therapeutics Private Limited, Bengaluru, India

Anil Kamat

4 Immuneel Therapeutics Private Limited, Bengaluru, India